Article
The clinical implications of gene mutations in chronic lymphocytic leukaemia.
British journal of cancer - 12 Apr 2016
Rossi Davide, Gaidano Gianluca
Abstract excerpt
Chronic lymphocytic leukaemia (CLL) is a molecularly heterogeneous disease as revealed by recent genomic studies. Among genetic lesions that are recurrent in CLL, few clinically validated prognostic markers, such as TP53 mutations and 17p deletion, are available for the use in clinical practice to guide treatment decisions. Recently, several novel molecular markers have been identified in CLL. Though these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
